Works by Goto, Koichi


Results: 152
    1
    2

    Improved Survival Outcomes in Patients With MET Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 7, p. 641, doi. 10.1016/j.cllc.2023.08.011
    By:
    • Wolf, Jurgen;
    • Souquet, Pierre-Jean;
    • Koichi Goto;
    • Cortot, Alexis;
    • Baik, Christina;
    • Heist, Rebecca;
    • Tae Min Kim;
    • Ji-Youn Han;
    • Neal, Joel W.;
    • Mansfield, Aaron S.;
    • Gilloteau, Isabelle;
    • Nwana, Ngozi;
    • Lynch, Maeve Waldron;
    • Davis, Keith L.;
    • Giovannini, Monica;
    • Awad, Mark M.
    Publication type:
    Article
    3
    4
    5
    6

    Rare Pulmonary Tumors –A Review of 32 Cases.

    Published in:
    Oncology, 1998, v. 55, n. 5, p. 431, doi. 10.1159/000011891
    By:
    • Sekine, Ikuo;
    • Kodama, Tetsuro;
    • Yokose, Tomoyuki;
    • Nishiwaki, Yutaka;
    • Suzuki, Kenji;
    • Goto, Koichi;
    • Nagai, Kanji;
    • Kuriyama, Takayuki
    Publication type:
    Article
    7

    Late Recurrence of Small-Cell Lung Cancer: Treatment and Outcome.

    Published in:
    Oncology, 1996, v. 53, n. 4, p. 318, doi. 10.1159/000227580
    By:
    • Sekine, Ikuo;
    • Nishiwaki, Yutaka;
    • Kakinuma, Ryutaro;
    • Kubota, Kaoru;
    • Hojo, Fumihiko;
    • Matsumoto, Taketoshi;
    • Ohmatsu, Hironobu;
    • Yokozaki, Michiya;
    • Goto, Koichi;
    • Kodama, Tetsuro
    Publication type:
    Article
    8

    Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening-triggered programme.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 4, p. 375, doi. 10.1093/jjco/hyab204
    By:
    • Matsumoto, Yoshihisa;
    • Umemura, Shigeki;
    • Okizaki, Ayumi;
    • Fujisawa, Daisuke;
    • Kobayashi, Naoko;
    • Tanaka, Yuko;
    • Sasaki, Chiyuki;
    • Shimizu, Ken;
    • Ogawa, Asao;
    • Kinoshita, Hiroya;
    • Uchitomi, Yosuke;
    • Yoshiuchi, Kazuhiro;
    • Matsuyama, Yutaka;
    • Morita, Tatsuya;
    • Goto, Koichi;
    • Ohe, Yuichiro
    Publication type:
    Article
    9

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    10
    11
    12
    13

    Docetaxel for platinum-refractory advanced thymic carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2015, v. 45, n. 7, p. 665, doi. 10.1093/jjco/hyv046
    By:
    • Naohiro Watanabe;
    • Shigeki Umemura;
    • Seiji Niho;
    • Keisuke Kirita;
    • Shingo Matsumoto;
    • Kiyotaka Yoh;
    • Hironobu Ohmatsu;
    • Koichi Goto
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Successful Treatment with Crizotinib to Overcome Drug Resistance Possibly Due to Mesenchymal-epithelial Transition Amplification in a Lung Cancer Patient with the Echinoderm Microtubule-associated Protein-like 4-anaplastic Lymphoma Kinase Fusion Gene.

    Published in:
    Internal Medicine, 2023, v. 62, n. 21, p. 3215, doi. 10.2169/internalmedicine.1164-22
    By:
    • Tomoko Shiraishi;
    • Kei Yamasaki;
    • Moe Kidogawa;
    • Tatsuya Shingu;
    • Fuki Ujimiya;
    • Takanobu Jotatsu;
    • Shingo Matsumoto;
    • Hiroki Izumi;
    • Chinatsu Nishida;
    • Koichi Goto;
    • Kazuhiro Yatera
    Publication type:
    Article
    28
    29
    30

    A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer.

    Published in:
    Medical Oncology, 2016, v. 33, n. 1, p. 1, doi. 10.1007/s12032-015-0715-7
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Kaneda, Hiroyasu;
    • Nakagawa, Kazuhiko;
    • Yoh, Kiyotaka;
    • Goto, Koichi;
    • Okamoto, Hiroaki;
    • Shimokawa, Tsuneo;
    • Abe, Tetsuya;
    • Tanaka, Hiroshi;
    • Daga, Haruko;
    • Takeda, Koji;
    • Hirashima, Tomonori;
    • Atagi, Shinji
    Publication type:
    Article
    31
    32
    33

    A secondary RET mutation in the activation loop conferring resistance to vandetanib.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-02994-7
    By:
    • Takashi Nakaoku;
    • Takashi Kohno;
    • Mitsugu Araki;
    • Seiji Niho;
    • Chauhan, Rakhee;
    • Knowles, Phillip P.;
    • Katsuya Tsuchihara;
    • Shingo Matsumoto;
    • Yoko Shimada;
    • Sachiyo Mimaki;
    • Genichiro Ishii;
    • Hitoshi Ichikawa;
    • Satoru Nagatoishi;
    • Kouhei Tsumoto;
    • Yasushi Okuno;
    • Kiyotaka Yoh;
    • McDonald, Neil Q.;
    • Koichi Goto
    Publication type:
    Article
    34
    35

    Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy.

    Published in:
    Clinical & Experimental Metastasis, 2023, v. 40, n. 5, p. 407, doi. 10.1007/s10585-023-10225-7
    By:
    • Oyoshi, Hidekazu;
    • Hirata, Hidenari;
    • Hirano, Yasuhiro;
    • Zenda, Sadamoto;
    • Zhou, Yuzheng;
    • Tomizawa, Kento;
    • Fujisawa, Takeshi;
    • Nakamura, Masaki;
    • Hojo, Hidehiro;
    • Motegi, Atsushi;
    • Kageyama, Shun-Ichiro;
    • Zenke, Yoshitaka;
    • Goto, Koichi;
    • Ishihara, Shunichi;
    • Naganawa, Shinji;
    • Akimoto, Tetsuo
    Publication type:
    Article
    36

    Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
    By:
    • Nosaki, Kaname;
    • Yoh, Kiyotaka;
    • Toyozawa, Ryo;
    • Horinouchi, Hidehito;
    • Morise, Masahiro;
    • Ohashi, Kadoaki;
    • Murakami, Haruyasu;
    • Satouchi, Miyako;
    • Sakakibara-Konishi, Jun;
    • Yano, Seiji;
    • Okumura, Fumihiko;
    • Matsumoto, Shingo;
    • Shimokawa, Mototsugu;
    • Seto, Takashi;
    • Goto, Koichi
    Publication type:
    Article
    37
    38
    39

    Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1828, doi. 10.1007/s10147-022-02232-7
    By:
    • Sugawara, Shunichi;
    • Kondo, Masashi;
    • Yokoyama, Toshihide;
    • Kumagai, Toru;
    • Nishio, Makoto;
    • Goto, Koichi;
    • Nakagawa, Kazuhiko;
    • Seto, Takashi;
    • Yamamoto, Nobuyuki;
    • Kudou, Kentarou;
    • Asato, Takayuki;
    • Zhang, Pingkuan;
    • Ohe, Yuichiro
    Publication type:
    Article
    40

    Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
    By:
    • Sugawara, Shunichi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Nokihara, Hiroshi;
    • Ohe, Yuichiro;
    • Nishio, Makoto;
    • Takahashi, Toshiaki;
    • Goto, Koichi;
    • Maemondo, Makoto;
    • Ichinose, Yukito;
    • Seto, Takashi;
    • Sakai, Hiroshi;
    • Gemma, Akihiko;
    • Imamura, Fumio;
    • Shingyoji, Masato;
    • Saka, Hideo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Okamoto, Isamu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    41

    Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0
    By:
    • Yamamoto, Noboru;
    • Goto, Koichi;
    • Nishio, Makoto;
    • Chikamori, Kenichi;
    • Hida, Toyoaki;
    • Maemondo, Makoto;
    • Katakami, Nobuyuki;
    • Kozuki, Toshiyuki;
    • Yoshioka, Hiroshige;
    • Seto, Takashi;
    • Tajima, Kosei;
    • Tamura, Tomohide
    Publication type:
    Article
    42
    43
    44
    45
    46

    Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 13, p. 1983, doi. 10.1111/1759-7714.14001
    By:
    • Miura, Kaho;
    • Sano, Yoshiyuki;
    • Niho, Seiji;
    • Kawasumi, Kenji;
    • Mochizuki, Nobuo;
    • Yoh, Kiyotaka;
    • Matsumoto, Shingo;
    • Zenke, Yoshitaka;
    • Ikeda, Takaya;
    • Nosaki, Kaname;
    • Kirita, Keisuke;
    • Udagawa, Hibiki;
    • Goto, Koichi;
    • Kawasaki, Toshikatsu;
    • Hanada, Kazuhiko
    Publication type:
    Article
    47
    48
    50